Related Experiment Video
Updated: May 2, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Role of Krüppel-like factor 4 and its binding proteins in vascular disease
Tadashi Yoshida1, Matsuhiko Hayashi
1Apheresis and Dialysis Center, School of Medicine, Keio University.
Abstract:
Krüppel-like factor 4(KLF4) is a zinc-finger transcription factor that plays a key role in cellular differentiation and proliferation during normal development and in various diseases, such as cancer. The results of recent studies have revealed that KLF4 is expressed in multiple vascular cell types, including phenotypically modulated smooth muscle cells(SMCs), endothelial cells and monocytes/macrophages and contributes to the progression of vascular diseases by activating or repressing the transcription of multiple genes via its associations with a variety of partner proteins. For example, KLF4 decreases the expression of markers of SMC differentiation by interacting with serum response factor, ELK1 and histone deacetylases. KLF4 also suppresses SMC proliferation by associating with p53. In addition, KLF4 enhances arterial medial calcification in concert with RUNX2. Furthermore, endothelial KLF4 represses arterial inflammation by binding to nuclear factor-κB. This article summarizes the role of KLF4 in vascular disease with a particular focus on in vivo studies and reviews recent progress in our understanding of the regulatory mechanisms involved in KLF4- mediated gene transcription.
Insights
Krüppel-like factor 4 (KLF4) influences vascular diseases by regulating genes in smooth muscle cells and endothelial cells. Understanding KLF4’s role is key to developing new treatments for vascular conditions.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Cell Biology
Background:
- Krüppel-like factor 4 (KLF4) is a transcription factor crucial for cell development.
- KLF4 is present in vascular cells like smooth muscle cells (SMCs), endothelial cells, and macrophages.
- KLF4 dysregulation is implicated in various diseases, including cancer and vascular pathologies.
Purpose of the Study:
- To summarize the role of KLF4 in vascular disease.
- To focus on in vivo studies investigating KLF4's function in the vasculature.
- To review the regulatory mechanisms of KLF4-mediated gene transcription in vascular contexts.
Main Methods:
- Review of in vivo studies on KLF4 in vascular disease.
- Analysis of KLF4's interactions with partner proteins (e.g., SRF, ELK1, p53, RUNX2, NF-κB).
- Examination of KLF4's effects on gene expression in vascular cells.
Main Results:
- KLF4 modulates SMC differentiation and proliferation through interactions with SRF, ELK1, and p53.
- KLF4 promotes arterial medial calcification in conjunction with RUNX2.
- Endothelial KLF4 suppresses arterial inflammation by inhibiting nuclear factor-κB (NF-κB) signaling.
Conclusions:
- KLF4 plays a multifaceted role in vascular disease progression.
- KLF4's interactions with various proteins dictate its function in different vascular cell types.
- Further research into KLF4 regulatory mechanisms is essential for therapeutic development in vascular diseases.
More Related Videos
08:30Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
09:10Human Saphenous Vein Endothelial Cell Isolation and Exposure to Controlled Levels of Shear Stress and Stretch
Published on: April 21, 2023
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Cytoskeletal Linker Proteins - Plakins
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...
Intracellular Signaling Affects Focal Adhesions
Some...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Vascular Spasm